Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions

The year 2020 was dominated by the COVID-19 pandemic, bringing with it unprecedented advancements in the fields of healthcare and therapeutic interventions as well as in vaccine and drug development. Nevertheless, several other advancements in various fields of medicine also deserve attention. Herei...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Sarah L, Bassetti, Matteo, Mangoni, Arduino A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837369/
https://www.ncbi.nlm.nih.gov/pubmed/33542739
http://dx.doi.org/10.7573/dic.2020-12-10
_version_ 1783642946286911488
author Anderson, Sarah L
Bassetti, Matteo
Mangoni, Arduino A
author_facet Anderson, Sarah L
Bassetti, Matteo
Mangoni, Arduino A
author_sort Anderson, Sarah L
collection PubMed
description The year 2020 was dominated by the COVID-19 pandemic, bringing with it unprecedented advancements in the fields of healthcare and therapeutic interventions as well as in vaccine and drug development. Nevertheless, several other advancements in various fields of medicine also deserve attention. Herein, the Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021.
format Online
Article
Text
id pubmed-7837369
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioExcel Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-78373692021-02-03 Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions Anderson, Sarah L Bassetti, Matteo Mangoni, Arduino A Drugs Context Editorial The year 2020 was dominated by the COVID-19 pandemic, bringing with it unprecedented advancements in the fields of healthcare and therapeutic interventions as well as in vaccine and drug development. Nevertheless, several other advancements in various fields of medicine also deserve attention. Herein, the Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021. BioExcel Publishing Ltd 2021-01-22 /pmc/articles/PMC7837369/ /pubmed/33542739 http://dx.doi.org/10.7573/dic.2020-12-10 Text en Copyright © 2021 Anderson SL, Bassetti M, Mangoni AA. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.
spellingShingle Editorial
Anderson, Sarah L
Bassetti, Matteo
Mangoni, Arduino A
Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
title Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
title_full Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
title_fullStr Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
title_full_unstemmed Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
title_short Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
title_sort drugs in context editorial: review of 2020 and what lies ahead in therapeutic interventions
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837369/
https://www.ncbi.nlm.nih.gov/pubmed/33542739
http://dx.doi.org/10.7573/dic.2020-12-10
work_keys_str_mv AT andersonsarahl drugsincontexteditorialreviewof2020andwhatliesaheadintherapeuticinterventions
AT bassettimatteo drugsincontexteditorialreviewof2020andwhatliesaheadintherapeuticinterventions
AT mangoniarduinoa drugsincontexteditorialreviewof2020andwhatliesaheadintherapeuticinterventions

Ejemplares similares